Stephen C. Turner serves as Executive at Protea Biosciences Group, Inc., where they oversee executive responsibilities. Since joining the company, Stephen C. Turner has executed 7 insider transactions totaling $6.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 3, 2016 involved receiving (via award) 533,333 shares valued at $42.7K.
Stephen C. Turner currently holds 533,333 shares of Protea Biosciences Group, Inc. (NONE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen C. Turner has been a net buyer of NONE stock. They have purchased $6.6K and sold $0 worth of shares.
Stephen C. Turner's most recent insider trade was on Nov 3, 2016, when they sold 533,333 shares at $0.08 per share.
Get notified when new Form 4 filings are submitted
| $0.15 |
| Discretionary |
| Jul 5, 2016 | PRGB | $3.6K | Purchase | 24,000 | $0.15 | Discretionary |
| Jul 30, 2013 | NONE | $0 | Purchase | 224,204 | $N/A | Discretionary |
| Jul 30, 2013 | NONE | $0 | Purchase | 224,204 | $N/A | Discretionary |
| Jul 30, 2013 | NONE | $0 | Purchase | 224,204 | $N/A | Discretionary |
| Jul 30, 2013 | NONE | $0 | Purchase | 224,204 | $N/A | Discretionary |